VAUGHAN, Ontario, January 8, 2019 /PRNewswire/ --
CannTrust Holdings Inc.
("CannTrust" or the "Company") (TSX: TRST), one of
Canada's leading, most trusted
licensed producers of cannabis and the 2018 Canadian Cannabis
Awards "Top Licensed Producer of the Year," announces that it has
applied to list its common shares on the New York Stock Exchange
(the "NYSE").
Listing of the Company's common shares
on the NYSE remains subject to the approval of the NYSE and the
satisfaction of all applicable listing and regulatory requirements.
In connection with the intended listing on the NYSE, the Company
has filed a registration statement on Form 40-F (the
"Registration Statement") with the United States Securities
and Exchange Commission (the "SEC"). The Registration
Statement has not yet been declared effective by the SEC. Upon
receipt of all required approvals and completion of the formal
listing process, the Company will publicly announce its first
trading date on the NYSE.
"CannTrust has firmly established
itself as one of the top licensed producers
in Canada with a global platform rooted in trust, science
and innovation," said Peter Aceto, CEO of CannTrust. "A
listing on the NYSE is a natural step forward in our evolution as
we look to broaden our investor base, increase the Company's
exposure and expand our business on an international scale."
About CannTrust
CannTrust is a federally regulated licensed producer of medical and
recreational cannabis in Canada.
Founded by pharmacists, CannTrust brings more than 40 years of
pharmaceutical and healthcare experience to the medical cannabis
industry and serves over 57,000 medical patients with its dried,
extract and capsule products. The Company operates its 450,000 sq.
ft. Niagara Perpetual Harvest Facility. The industry's broadest
product portfolio is prepared and packaged at the 60,000 sq. ft.
manufacturing centre of excellence in Vaughan, Ontario.
CannTrust is developing nanotechnology
to develop new products in the medical, recreational, beauty,
wellness and pet markets. The Company has established its
international footprint through a strategic partnership with
Cannatrek Ltd. in Australia and a
joint venture with STENOCARE in Denmark. The Company has also partnered with
Breakthru Beverage Group through Kindred Canada, for recreational
distribution in Canada. CannTrust
is committed to research and innovation. Its partnerships with
McMaster University in Ontario and Gold
Coast University in Australia were designed to contribute to the
growing body of evidence-based research regarding the use and
efficacy of cannabis.
CannTrust was proudly voted Top
Licensed Producer of the Year at the 2018 Canadian Cannabis Awards.
For more information, please visit
http://www.canntrust.ca.
Forward Looking
Statements
This press release contains
"forward-looking information" and "forward-looking statements"
within the meaning of applicable securities legislation which are
based upon CannTrust's current internal expectations, estimates,
projections, assumptions and beliefs and views of future events.
Forward-looking information and forward-looking statements can be
identified by the use of forward-looking terminology such as
"expect", "likely", "may", "will", "should", "intend",
"anticipate", "potential", "proposed", "estimate" and other similar
words, including negative and grammatical variations thereof, or
statements that certain events or conditions "may", "would" or
"will" happen, or by discussions of strategy.
The forward-looking information and
statements in this news release are based upon the expectations,
estimates, projections, assumptions and views of future events
which management believes to be reasonable in the circumstances.
Forward-looking information and statements includes estimates,
plans, expectations, opinions, forecasts, projections, targets,
guidance or other statements that are not statements of fact.
Forward-looking statements in this news release include, but are
not limited to, statements with respect to the approval to list the
Company's common shares on the NYSE. Forward-looking information
and statements necessarily involve known and unknown risks,
including, without limitation: risks associated with general
economic conditions; adverse industry events; loss of markets;
future legislative and regulatory developments; the cannabis
industry in Canada generally; the ability of CannTrust to
implement its business strategies; obtaining NYSE and SEC approval
to list CannTrust's common shares; any delays related to obtaining
such approvals as a result of the current shutdown of the US
Federal government and other risks.
Any forward-looking information and
statements speaks only as of the date on which they are made, and,
except as required by law, CannTrust does not undertake any
obligation to update or revise any forward-looking information or
statements, whether as a result of new information, future events
or otherwise. New factors emerge from time to time, and it is not
possible for CannTrust to predict all such factors. When
considering these forward-looking information and statements,
readers should keep in mind the risk factors and other cautionary
statements in CannTrust's Annual Information Form dated March
29, 2018 (the "AIF") and filed with the applicable
Canadian securities regulatory authorities on SEDAR
at http://www.sedar.com. The risk factors and other factors
noted in the AIF could cause actual events or results to differ
materially from those described in any forward-looking information
or statements.
The TSX does not accept responsibility
for the adequacy or accuracy of this release.
Copyright © 2019 CannTrust Holdings
Inc.
For further information or to arrange
an interview, please contact:
Media
Relations:
Sybil Eastman
media@canntrust.ca
Investor Relations:
Marc Charbin
+1-416-519-2156 x2232
investor@canntrust.ca